Masson's tumor in the ulnar artery

Chang, Kevin; Barlaben, Andrew; Farley, Steven

doi:10.1016/j.jvs.2012.01.010

Cited by 14 publications

(11 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As a rare disease, IPEH has no distinct or defining radiological appearance, with nonspecific and variable findings again. 14,[30][31][32] Our case highlights the varied appearance of IPEH on ultrasonography. The main role of imaging is to identify vascular lesions, whereby modalities include ultrasonography, computed tomography, magnetic resonance imaging (MRI) and color Doppler sonography; however, it is difficult to differentiate IPEH from other malignant neoplasms.…”

Section: Discussionmentioning

confidence: 74%

Intravascular Papillary Endothelial Hyperplasia: Case Report of a Recurrent Masson’s Tumor of the Finger and Review of Literature

Sio

Desai

et al. 2021

Journal of Hand and Microsurgery

View full text Add to dashboard Cite

Intravascular papillary endothelial hyperplasia (IPEH), often referred to as Masson’s Tumor, is an uncommon yet benign vascular disease of the skin and subcutaneous tissues. It usually arises within a blood vessel, but is considered to be a non-neoplastic reactive endothelial proliferation commonly associated with vascular injury. Although it is rare, knowledge of this disease is important as it may mimic other benign and malignant tumors, especially angiosarcoma, which may lead to unnecessary aggressive management. Typically, IPEHs are asymptomatic and are slow growing soft-tissue masses with extremely low-recurrence rates. In this article, we describe a 19-year-old male with a recurrence of Masson’s Tumor over the right little finger within 2 months of a routine excision of the lesion. We also present accompanying multimodality clinical, radiological, and pathological imaging. This case illustrates the innocuous nature of the initial lesion easily mistaken for a hemangioma. Awareness of the possibility of a recurrence of a Masson’s Tumor is important for clinicians to rule out the presence of malignant vascular lesions.

show abstract

Section: Discussionmentioning

confidence: 74%

Intravascular Papillary Endothelial Hyperplasia: Case Report of a Recurrent Masson’s Tumor of the Finger and Review of Literature

Sio

Desai

et al. 2021

Journal of Hand and Microsurgery

View full text Add to dashboard Cite

show abstract

“…7,19 On Doppler ultrasound, it appears as a hypervascular lesion, whereas on computed tomography and magnetic resonance imaging, it appears as a contrast enhancing homogeneous mass. 7,10 Owing to a lack of consistent and specific radiological findings, microscopic histological diagnosis remains the standard method for diagnosing IPEH. 2,13,18 However, it can be challenging, as IPEH closely resembles angiosarcoma.…”

Section: Discussionmentioning

confidence: 99%

Intravascular Papillary Endothelial Hyperplasia (Masson Tumor) of the Right Thumb: A Case Report and Literature Review

Alkabbaa,

Alassaf,

Alothman

et al. 2023

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Summary: The Masson tumor is a benign vascular tumor named after Pierre Masson, the French pathologist who originally described it in 1923, terming it “hémangio-endothéliome végétant intravasculaire.” It is a rare tumor that can arise in any area throughout the body. However, the exact cause of Masson tumor remains poorly understood, and its diagnosis is challenging and difficult to distinguish from several other soft-tissue tumors. In this report, we report a case of Masson tumor arising in the right thumb that is only the second reported case in the hand in Saudi Arabia.

show abstract

“… 1 Although the case reported was not related to any predisposing factor, in the literature this lesion is usually related to irradiation and chronic trauma, that may change the venous and arterial flow 3 causing papillary endothelial proliferation. There is no age predilection (ranging from 9 months to 80 years old) and it occurs equally in males and females, but Chang in 2012 6 suggested a female predilection mainly due to the tumor's response to estrogens and progesterone.…”

Section: Discussionmentioning

confidence: 99%